XML 43 R22.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS
12 Months Ended
Mar. 31, 2021
Intangible Assets [Abstract]  
INTANGIBLE ASSETS INTANGIBLE ASSETS 
CapitalizedERP andOther 
 (amounts in millions)
 GoodwilldevelopmentCustomerotherintangible
(Note 29)
costsrelationshipsLicensessoftwareassetsTotal
Net book value as at March 31, 2019$1,067.7 $210.6 $322.8 $324.4 $70.7 $31.7 $2,027.9 
Additions – internal development — 86.2 — — 12.0 — 98.2 
Additions – acquired separately— — — 1.8 — 0.6 2.4 
Additions – business combinations (Note 4)20.1 5.8 13.0 (7.0)— — 31.9 
Amortization — (39.6)(34.7)(12.8)(14.1)(4.9)(106.1)
Impairment(37.5)(3.2)— — — — (40.7)
Transfers and others — (11.1)2.9 (2.7)4.1 — (6.8)
Foreign currency exchange differences 35.0 0.8 8.0 5.0 0.3 0.6 49.7 
Net book value as at March 31, 2020$1,085.3 $249.5 $312.0 $308.7 $73.0 $28.0 $2,056.5 
Additions – internal development — 48.6 — — 6.8 — 55.4 
Additions – acquired separately— — — — — 0.6 0.6 
Additions – business combinations (Note 4)169.0 — 47.9 — 0.7 2.2 219.8 
Amortization — (44.6)(29.7)(17.6)(13.4)(4.0)(109.3)
Impairment— (41.4)(9.3)— — (1.1)(51.8)
Transfers and others — 5.3 (0.9)(0.9)(1.4)0.4 2.5 
Foreign currency exchange differences (81.1)(1.7)(22.5)(10.8)(0.5)(1.3)(117.9)
Net book value as at March 31, 2021$1,173.2 $215.7 $297.5 $279.4 $65.2 $24.8 $2,055.8 
 
    
 Capitalized
ERP and

Other 
GoodwilldevelopmentCustomerotherintangible
(Note 29)
costsrelationshipsLicensessoftware
assets

Total
Cost$1,122.8 $454.2 $486.1 $326.2 $213.3 $98.3 $2,700.9 
Accumulated amortization and impairment(37.5)(204.7)(174.1)(17.5)(140.3)(70.3)(644.4)
Net book value as at March 31, 2020$1,085.3 $249.5 $312.0 $308.7 $73.0 $28.0 $2,056.5 
Cost$1,210.7 $433.6 $482.6 $313.6 $215.6 $94.6 $2,750.7 
Accumulated amortization and impairment(37.5)(217.9)(185.1)(34.2)(150.4)(69.8)(694.9)
Net book value as at March 31, 2021$1,173.2 $215.7 $297.5 $279.4 $65.2 $24.8 $2,055.8 

During the year ended March 31, 2021, amortization of $63.8 million (2020 – $65.8 million) has been recorded in cost of sales, $43.6 million (2020 – $38.5 million) in research and development expenses and $1.9 million (2020 – $1.8 million) in selling, general and administrative expenses.